Note: Practice guidelines published prior to 2010 are not listed on this page.
General guidelines
Lingford-Hughes AR, Welch S, Peters L, Nutt DJ; British Association for Psychopharmacology, Expert Reviewers Group. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol. 2012 Jul;26(7):899-952. doi: 10.1177/0269881112444324. Epub 2012 May 23. PubMed PMID: 22628390.
Alcohol use disorder
American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder
Butt PR, White-Campbell M, Canham S, Johnston AD, Indome EO, Purcell B, Tung J, Van Bussel L. Canadian Guidelines on Alcohol Use Disorder Among Older Adults. Can Geriatr J. 2020 Mar 30;23(1):143-148. doi: 10.5770/cgj.23.425. PMID: 32226573; PMCID: PMC7067152.
Reus VI, Fochtmann LJ, Bukstein O, Eyler AE, Hilty DM, Horvitz-Lennon M, Mahoney J, Pasic J, Weaver M, Wills CD, McIntyre J, Kidd J, Yager J, Hong SH. The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder. Am J Psychiatry. 2018 Jan 1;175(1):86-90. PubMed PMID: 29301420. See Simple and Practical Medical Education‘s summary of this guideline in the following article: APA Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder
Soyka M, Kranzler HR, Hesselbrock V, Kasper S, Mutschler J, Möller HJ; WFSBP Task Force on Treatment Guidelines for Substance Use Disorders. Guidelines for biological treatment of substance use and related disorders, part 1: Alcoholism, first revision. World J Biol Psychiatry. 2017 Mar;18(2):86-119. doi: 10.1080/15622975.2016.1246752. Epub 2016 Dec 23. Review. PubMed PMID: 28006997.
Cannabis use disorder
Bertram JR, Porath A, Seitz D, Kalant H, Krishnamoorthy A, Nickerson J, Sidhu A, Smith A, Teed R. Canadian Guidelines on Cannabis Use Disorder Among Older Adults. Can Geriatr J. 2020 Mar 30;23(1):135-142. doi: 10.5770/cgj.23.424. PMID: 32226572; PMCID: PMC7067149.
Opioid use disorders
American Society of Addiction Medicine. The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update. J Addict Med. 2020 Mar/Apr;14(2S Suppl 1):1-91. doi: 10.1097/ADM.0000000000000633. Erratum in: J Addict Med. 2020 May/Jun;14(3):267. PMID: 32511106.
Bruneau J, Ahamad K, Goyer MÈ, Poulin G, Selby P, Fischer B, Wild TC, Wood E; CIHR Canadian Research Initiative in Substance Misuse. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018 Mar 5;190(9):E247-E257. doi: 10.1503/cmaj.170958. PubMed PMID: 29507156; PubMed Central PMCID: PMC5837873.
Crotty K, Freedman KI, Kampman KM. Executive Summary of the Focused Update of the ASAM National Practice Guideline for the Treatment of Opioid Use Disorder. J Addict Med. 2020 Mar/Apr;14(2):99-112. doi: 10.1097/ADM.0000000000000635. Erratum in: J Addict Med. 2020 May/Jun;14(3):267. PMID: 32209915.
Fairbairn N, Ross J, Trew M, Meador K, Turnbull J, MacDonald S, Oviedo-Joekes E, Le Foll B, Goyer MÈ, Perreault M, Sutherland C. Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline. CMAJ. 2019 Sep 23;191(38):E1049-E1056. doi: 10.1503/cmaj.190344. PMID: 31548191; PMCID: PMC6763328.
Farmer CM, Lindsay D, Williams J, Ayers A, Schuster J, Cilia A, Flaherty MT, Mandell T, Gordon AJ, Stein BD. Practice Guidance for Buprenorphine for the Treatment of Opioid Use Disorders: Results of an Expert Panel Process. Subst Abus. 2015;36(2):209-16. doi: 10.1080/08897077.2015.1012613. Epub 2015 Apr 6. PubMed PMID: 25844527; PubMed Central PMCID: PMC4470850.
Kampman K, Jarvis M. American Society of Addiction Medicine (ASAM) National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. 2015 Sep-Oct;9(5):358-67. doi: 10.1097/ADM.0000000000000166. PMID: 26406300; PMCID: PMC4605275.
Korownyk C, Perry D, Ton J, Kolber MR, Garrison S, Thomas B, Allan GM, Bateman C, de Queiroz R, Kennedy D, Lamba W, Marlinga J, Mogus T, Nickonchuk T, Orrantia E, Reich K, Wong N, Dugré N, Lindblad AJ. Managing opioid use disorder in primary care: PEER simplified guideline. Can Fam Physician. 2019 May;65(5):321-330. Erratum in: Can Fam Physician. 2019 Oct;65(10):687. Erratum in: Can Fam Physician. 2019 Oct;65(10):687. PMID: 31088869; PMCID: PMC6516701.
NICE. 2019 surveillance of drug misuse in over 16s: opioid detoxification (NICE guideline CG52) [Internet]. London: National Institute for Health and Care Excellence (UK); 2019 Jan 3. PMID: 31825576.
Rieb LM, Samaan Z, Furlan AD, Rabheru K, Feldman S, Hung L, Budd G, Coleman D. Canadian Guidelines on Opioid Use Disorder Among Older Adults. Can Geriatr J. 2020 Mar 30;23(1):123-134. doi: 10.5770/cgj.23.420. PMID: 32226571; PMCID: PMC7067148.
Saxon AJ, McCance-Katz EF. Some Additional Considerations Regarding the American Society of Addiction Medicine National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use. J Addict Med. 2016 May-Jun;10(3):140-2. doi: 10.1097/ADM.0000000000000219. PubMed PMID: 27223833.
Soyka M, Kranzler HR, van den Brink W, Krystal J, Möller HJ, Kasper S; WFSBP Task Force on Treatment, Guidelines for Substance Use Disorders. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence. World J Biol Psychiatry. 2011 Apr;12(3):160-87. doi: 10.3109/15622975.2011.561872. Erratum in: World J Biol Psychiatry. 2011 Aug;12(5):397. Lingford-Hughes, Anne [removed]. PubMed PMID: 21486104.
Tobacco use disorder
Patnode CD, Henderson JT, Coppola EL, Melnikow J, Durbin S, Thomas RG. Interventions for Tobacco Cessation in Adults, Including Pregnant Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2021 Jan 19;325(3):280-298. doi: 10.1001/jama.2020.23541. PMID: 33464342.
Leone FT, Zhang Y, Evers-Casey S, Evins AE, Eakin MN, Fathi J, Fennig K, Folan P, Galiatsatos P, Gogineni H, Kantrow S, Kathuria H, Lamphere T, Neptune E, Pacheco MC, Pakhale S, Prezant D, Sachs DPL, Toll B, Upson D, Xiao D, Cruz-Lopes L, Fulone I, Murray RL, O’Brien KK, Pavalagantharajah S, Ross S, Zhang Y, Zhu M, Farber HJ. Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020 Jul 15;202(2):e5-e31. doi: 10.1164/rccm.202005-1982ST. PMID: 32663106; PMCID: PMC7365361.
Barua RS, Rigotti NA, Benowitz NL, Cummings KM, Jazayeri MA, Morris PB, Ratchford EV, Sarna L, Stecker EC, Wiggins BS. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018 Dec 25;72(25):3332-3365. doi: 10.1016/j.jacc.2018.10.027. Epub 2018 Dec 5. PMID: 30527452.
Substance use disorders comorbid with other conditions
Abou Saleh M, Crome I. National Institute for Health and Clinical Excellence (NICE) guideline: psychosis with coexisting substance misuse. Addiction. 2012 Jan;107(1):1-3. doi: 10.1111/j.1360-0443.2011.03542.x. Epub 2011 Sep 21. PubMed PMID: 21939460.
Beaulieu S, Saury S, Sareen J, Tremblay J, Schütz CG, McIntyre RS, Schaffer A; Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid substance use disorders. Ann Clin Psychiatry. 2012 Feb;24(1):38-55. Review. PubMed PMID: 22303521.
Crockford D, Addington D. Canadian Schizophrenia Guidelines: Schizophrenia and Other Psychotic Disorders with Coexisting Substance Use Disorders. Can J Psychiatry. 2017 Sep;62(9):624-634. doi: 10.1177/0706743717720196. Review. PubMed PMID: 28886671; PubMed Central PMCID: PMC5593250.
Hasan A, Falkai P, Wobrock T, Lieberman J, Glenthøj B, Gattaz WF, Thibaut F, Möller HJ; WFSBP Task Force on Treatment Guidelines for Schizophrenia. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. Part 3: Update 2015 Management of special circumstances: Depression, Suicidality, substance use disorders and pregnancy and lactation. World J Biol Psychiatry. 2015 Apr;16(3):142-70. doi: 10.3109/15622975.2015.1009163. PubMed PMID: 25822804.
Kendall T, Tyrer P, Whittington C, Taylor C; Guideline Development Group. Assessment and management of psychosis with coexisting substance misuse: summary of NICE guidance. BMJ. 2011 Mar 23;342:d1351. doi: 10.1136/bmj.d1351. PubMed PMID: 21430003.
Reece-Stremtan S, Marinelli KA. ABM clinical protocol #21: guidelines for breastfeeding and substance use or substance use disorder, revised 2015. Breastfeed Med. 2015 Apr;10(3):135-41. doi: 10.1089/bfm.2015.9992. Review. PubMed PMID: 25836677; PubMed Central PMCID: PMC4378642.
Related Pages
Practice guidelines in mental health: Overview
Tips on how to use practice guidelines
Practice guidelines for attention-deficit/ hyperactivity disorder (ADHD)
Practice guidelines for autism spectrum disorder
Practice guidelines for bipolar disorders
Practice guidelines for delirium
Practice guidelines for dementias
Practice guidelines for depressive disorders
Practice guidelines for eating disorders
Practice guidelines for insomnia disorder
Practice guidelines for obsessive-compulsive disorders (OCD)
Practice guidelines for posttraumatic stress disorder (PTSD)
Practice guidelines for schizophrenia
Practice guidelines for substance-related and addictive disorders
Practice guidelines for suicidality and self-harm
Main Menu
Mental disorders and related conditions: Main menu
Copyright © 2020 Simple and Practical Medical Education, LLC. All rights reserved. May not be reproduced in any form without express written permission.
Disclaimer: The content on this website is provided as general education for medical professionals. It is not intended or recommended for patients or other laypersons or as a substitute for medical advice, diagnosis, or treatment. Patients must always consult a qualified health care professional regarding their diagnosis and treatment. Healthcare professionals should always check this website for the most recently updated information.
Leave a Reply: